发明申请
US20080300281A1 Inhibition of p38 Kinase Activity Using Aryl and Heteroaryl Substituted Heterocyclic Ureas
审中-公开
使用芳基和杂芳基取代的杂环脲抑制p38激酶活性
- 专利标题： Inhibition of p38 Kinase Activity Using Aryl and Heteroaryl Substituted Heterocyclic Ureas
- 专利标题（中）： 使用芳基和杂芳基取代的杂环脲抑制p38激酶活性
-
申请号： US12181032申请日： 2008-07-28
-
公开(公告)号： US20080300281A1公开(公告)日： 2008-12-04
- 发明人: Jacques Dumas , Uday Khire , Timothy B. Lowinger , Bernd Riedl , William J. Scott , Roger A. Smith , Jill E. Wood , Holia Hatoum-Mokdad , Jeffrey Johnson , Aniko Redman , Robert Sibley
- 申请人： Jacques Dumas , Uday Khire , Timothy B. Lowinger , Bernd Riedl , William J. Scott , Roger A. Smith , Jill E. Wood , Holia Hatoum-Mokdad , Jeffrey Johnson , Aniko Redman , Robert Sibley
- 主分类号： A61K31/4439
- IPC分类号： A61K31/4439 ; A61K31/415 ; A61K31/4427 ; A61K31/381 ; A61P19/02
摘要：
This invention relates to the use of a group of aryl ureas in treating cytokine mediated diseases other than cancer and proteolytic enzyme mediated diseases other than cancer, and pharmaceutical compositions for use in such therapy.